Providing humoral immunity, antibody-secreting plasma cells and their immediate precursors, the plasmablasts, are generated in systemic and mucosal immune reactions. Despite their key role in maintaining immunity and immunopathology, little is known about their homeostasis. Here we show that plasmablasts and plasma cells are detectable in human blood at low frequency in any unimmunized donor at any time. In this steady-state, 80% of plasmablasts and plasma cells express IgA. 
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Expression of a functional mucosal chemokine receptor (CCR10) and the adhesion molecule β 7 -integrin suggests that these cells come from mucosal immune reactions and can home back to mucosal tissue. These blood-borne, CCR10
+ plasmablasts also express CXCR4 and are attracted by CXCL12. About 40% of plasma cells in human bone marrow produce IgA, are non-migratory and express 
Introduction
Protective humoral immunity is provided by plasma cells through the production of antibodies. Since the half-life of the secreted immunoglobulin (Ig) is limited to a maximum of 2-3 weeks 1 , persisting humoral immunity must be regulated through mechanisms controlling generation, survival and homeostasis of plasma cells, i.e.
terminally differentiated B cells that are generated from activated B cells [2] [3] [4] [5] . In a secondary systemic immune response to a protein antigen like tetanus toxoid,
antigen-specific IgG-secreting plasmablasts with somatically mutated V H gene rearrangements are generated from memory B cells 6, 7 . After leaving the secondary lymphoid tissues, they are detectable in human blood between days 6 and 8 after vaccination. At this time, they are migratory and attracted by CXCL12, i.e. could migrate to tissues, such as bone marrow 6 . In the bone marrow, plasmablasts, expressing high HLA-DR, proliferating and being migratory, can differentiate into long-lived plasma cells, which are no longer migratory, express low HLA-DR and do not proliferate and continue to secrete their antibodies, thus maintaining humoral memory 8, 9 , independent of circulating CD20 + B cells, as shown in patients treated with anti-CD20 (rituximab) 10, 11 . Humoral immunity can also be driven by persisting antigen, and the continuous differentiation of B cells into short-lived plasma cells 3, 12 .
Survival of plasma cells in vivo depends on specific signals from their environment, the plasma cells niche 13 . The number of niches most likely limits the number of plasma cells in the body 14 . Entry into and egress from survival niches thus probably determines the homeostasis of plasma cells specific for a certain antigen. Recently, in accordance with this hypothesis, the mobilization of plasma cells of diverse specificities by tetanus toxoid-specific plasmablasts after tetanus vaccination has been reported 6 . Trafficking and localization of plasmablasts and plasma cells in the body/tissue is mediated by homing receptors and chemokine receptors 15 . The 16, 17 , and with the mucosal addressin cell-adhesion molecule-1 20, 27 . It has also been demonstrated that CCR9
and its ligand CCL25 mediate homing of plasmablasts expressing this chemokine receptor into intestinal tissue 28, 29 . Plasmablasts generated in systemic immune responses do not express CCR9 or CCR10, but do express CXCR4 30, 31 . CXCL12, the ligand of CXCR4, is expressed abundantly in human tissues including spleen, bone marrow, lymph nodes 32 , and mucosal tissues 33 , and mediates recruitment of CXCR4 + plasmablasts into bone marrow 30, 31 . 
Material & Methods
Preparation of blood and bone marrow samples Citrate or heparinized whole blood from healthy donors (18-57 years of age, average 35 years) was collected and peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation as described before 6 , using lymphocyte separation medium (PAA Laboratories, Pasching, Germany).
Some donors were immunized with tetanus/diphtheria vaccine (Aventis-Pasteur MSD, Leimen, Germany) after informed consent from each donor had been obtained. For personal use only. on January 15, 2018. by guest www.bloodjournal.org From Transwell migration assay For assessment of chemotactic attraction, a chemotaxis assay was used as described previously 6, 30, 38 . Briefly, 24-well plates with transwell inserts (6.5mm diameter, 5µm pore size; Corning, Schiphol, The Netherlands) and RPMI 1640 medium (Life Technologies, Paisley, UK) supplemented with 0.5% BSA (low endotoxin; Sigma-Aldrich) were used. The inserts were coated with 100µl human fibronectin solution (Invitrogen, Karlsruhe, Germany) at a concentration of 10µg/ml in distilled water and incubated for 1h at 37°C and 5% CO 2 . The solution was removed and the inserts were dried for 2 hrs at 37°C.
PBMCs or bone marrow mononuclear cells were isolated as described above, using pre-warmed RPMI1640 instead of buffers. For some experiments, B cells were Twenty-three individuals were tested 6-7 days after secondary systemic vaccination with tetanus/diphtheria toxoid. In these donors, a significantly increased frequency of plasmablasts and plasma cells was observed (p<0.0001, Mann-Whitney test, 95%
CI) with a median of 0.46% ± 0.5% of PBMCs (range 0.08% to 2.06%). The absolute count of blood-borne plasmablasts/plasma cells in steady-state was 2307/ml ± 657/ml (19 donors). In all donors, when absolute cell numbers were assessed directly before and 7 days after vaccination with tetanus/diphtheria toxoid, increased absolute counts of plasmablasts/plasma cells were observed following immunization (supplementary Figure 1C) .
Steady-state blood-borne plasmablasts/plasma cells express IgA, In steady-state, most peripheral CD19 + /CD27 high cells expressed the C-C motif receptor 10 (CCR10) (56% ± 19%, range 16 -79%, 7 donors) ( Figure 3D ), a chemokine receptor functionally expressed by lymphocytes in mucosal tissues of airways and gut 39, 41 , mammary gland 42 donors) ( Figure 3E ). Seven days after tetanus/diphtheria vaccination, blood-borne, vaccine-specific plasmablasts did not express CCR10. At this time point, the overall frequency of CCR10-expressing cells among total plasmablasts/plasma cells was significantly reduced (18% ± 11%; range 9 -33%, 4 donors) ( Figure 3F were 16%, 21%, 37% and 34% (4 donors). 18%, 25%, 12% and 30% of plasmablasts migrated towards a gradient of CXCL12 (10nM), and <2% migrated towards the intestinal chemokine CCL25, the ligand of CCR9. Steady-state plasmablasts migrating towards CCL28 all expressed CCR10 (2 donors tested). Of the plasmablasts migrating towards CXCL12, most IgA + cells also expressed CCR10, but only few of the IgA -cells ( Figure 4D ).
For personal use only. on January 15, 2018. by guest www.bloodjournal.org From After vaccination with tetanus/diphtheria toxoid, the frequencies of plasmablasts migrating towards CXCL12 were 15% ± 13% (10 donors, median ± SD), and barely any cells could be detected migrating towards CCL25 (<1%), as compared to assay medium (<1%), in 2 donors tested ( Figure 4B ). At this time, antigen-specific cells and most of all plasmablasts/plasma cells did not express CCR10, implicating a significantly lower migration as response towards CCL28 as compared to steadystate.
As expected, less than 0.6% of plasma cells from bone marrow migrated to any of the chemokines tested, i.e. more than 99% of bone marrow plasma cells were nonmigratory ( Figure 4C ), despite the finding that bone marrow plasma cells do express CXCR4 and CCR10, but not CCR9 ( Figure 6B ).
Coexistence of plasmablasts and plasma cells in steady-state blood
The mature phenotype of bone marrow plasma cells, as shown in Figure 5 , was consistent with previous results obtained in mice 30 . Bone marrow plasma cells expressed high levels of CD38, CD138 and intracellular Ig (supplementary Figure 2) .
Few if any expressed Ki-67 (5% ± 3%), high levels of HLA-DR (12% ± 6%) or CD62L (2% ± 5%) ( Figure 5B ). Expression of For personal use only. on January 15, 2018. by guest www.bloodjournal.org From
Discussion
The homeostasis of antibody-secreting cells providing humoral immunity is still poorly understood. Plasma cells are residing mainly in bone marrow, but also in secondary lymphoid tissue and mucosal tissue. Their survival apparently depends on signals provided by their environment, the plasma cell niche 13 . It remains controversial whether these plasma cells are continuously replaced 3, 12 or only as a consequence of subsequent immune reactions 6, 44 . Evidence for the mobilization of memory plasma cells into the blood in the course of an immune reaction has been provided by a previous study 6 . It remained unclear, whether such a mobilization does also occur continuously in steady-state, implying a corresponding constant (chronic) generation of new plasmablasts to maintain the observed stability of humoral memory 3, 45 .
Antibody-secreting cells of blood in steady-state have been analyzed phenotypically before. Arce et al. identified IgG-secreting cells of blood by the cytometric secretion assay and showed that these cells are heterogeneous with respect to expression of HLA-DR and CD38 35 , and speculated that the CD38 low expressing IgG-secreting cells in blood might be plasmablasts 35, 46 . Moreover, Johansen et al have detected circulating CD19 dim /IgA dim cells in steady-state and speculated on their mucosal origin 47 .
Here we have analyzed the phenotype and migratory potential of distinct antibodysecreting cells of peripheral blood to determine their possible origin and destination by applying different degrees of immune activation. In accordance with previous data, we found that in steady-state, 11.5 x 10 6 antibody-secreting cells are circulating in 5l of blood, as compared to 5.5 x 10 8 residing in bone marrow and 6.5 x 10 9 in the gutassociated lymphoid tissue 48, 49 . More than eighty percent of the circulating antibody- Thirdly, the continuous influx of steady-state "mucosal" plasmablasts into bone marrow would result in 80% of the plasma cells in the bone marrow secreting IgA. This is not observed, the frequency of IgA-secreting bone marrow plasma cells is about 40% (Figure 6 ). Therefore, the chronic production of IgA + plasmablasts does not substantially impact on IgG + plasma cell memory. . Expression of CCR10 is induced in mucosal immune reactions of the Figure 3) . The recruitment of IgA-secreting cells from distinct mucosal immune responses has been described for mice infected with rotavirus 58 . The difference between steady-state plasmablasts and plasmablasts generated during infection with regard to their competence to join the pool of bone marrow memory plasma cells appears to be crucial for the development of mucosal vaccines and our understanding of immunity to mucosal virus challenge. HLA-DR Ki-67 CD62L
